|
|
|
Stem Cell Related Patent Number US6759244
| Title: | Composite blastocysts (CBs) from aggregates of dissociated cells of non-viable pre-embryos | | Inventors: | Alikani, Mina; New York, NY, USA
Willadsen, Steen Malte; Windermere, FL, USA | | Summary: | This invention discloses a preparation and a method of making composite blastocysts (CBs) from aggregates of dissociated cells of non-viable pre-embryos. The CB is characterized morphologically by having two distinct tissue types, the inner cell mass (ICM) and the trophectoderm (TE), and a blastocoelic cavity (BC). The method of making CBs is an aggregation process (AP) comprising the dissociation of discarded pre-embryos, the isolation of single nucleated cells from dissociated discarded pre-embryos, the microsurgical encapsulation of several cells within a host zona pellucida or artificial aggregation with or without a non-zona vessel, and a primary culture of the cell aggregates for multiplication and differentiation of cells. Further advantages from using starting material that consists of non-viable pre-embryos, as well as the processes of novel aggregation from the CBs, are further disclosed. | | Abstract: | A preparation and a method of making composite blastocysts (CBs) from aggregates of dissociated cells of non-viable pre-embryos are disclosed. The CB is characterized morphologically by having two distinct tissue types, the inner cell mass (ICM) and the trophectoderm (TE), and a blastocoelic cavity (BC). The method of making CBs is an aggregation process (AP) comprising inter alia the following steps: 1) dissociation of discarded pre-embryos; 2) isolation of single nucleated cells from dissociated discarded pre-embryos; 3) microsurgical encapsulation of several cells within a host zona pellucida or artificial aggregation with or without a non-zona vessel; and 5) primary culture of the cell aggregates for multiplication and differentiation of cells. One particularly advantageous embodiment is that the starting material is non-viable pre-embryos. Another advantageous embodiment is that the AP allows individual cells from non-viable pre-embryos to further multiply, and become integrated into CBs. The novel CBs and the novel aggregation process disclosed.
One particularly advantageous embodiment is that the starting material is non-viable pre-embryos. Another advantageous embodiment is that the AP allows individual cells from non-viable pre-embryos to further multiply, and become integrated into CBs. The novel CBs and the novel aggregation process are disclosed. | | US Patent Website: | Click Here for Full Text of Patent | | Title Number: | US6759244 | | Application Number: | US2001000036581 | | Date Filed: | 08/11/2001 | | Date Published: | 06/07/2004 | | Assignee: | Art Institute of New York and New Jersey, Inc., New York, NY, USA |
|
|
